Evidence map›Paper›PMID 37988439›Full record

ArticleCirculation. Cardiovascular interventions2023

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study.

Gilbert H L Tang, Julianne Spencer, Toby Rogers, Kendra J Grubb, Patrick Gleason, Hemal Gada, Paul Mahoney, Harold L Dauerman, John K Forrest, Michael J Reardon and 18 more

Registry-linked trialAbstract read
In one paragraph

Article in Circulation. Cardiovascular interventions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02701283 (Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02701283 naactive not recruitingnot on this map

Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement

TypeinterventionalSponsorMedtronic CardiovascularRan2016 to 2029Enrolled2,223ConditionsAortic Valve StenosisArmsMedtronic Transcatheter Aortic Valve Replacement Systems, Surgical Aortic Valve Replacement (SAVR)
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Clinical Outcomes of the Allegra Transcatheter System in Bioprosthetic Aortic Valve Failure: A Multicentre Valve-in-Valve Registry.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  4. Lifetime Planning of Aortic Stenosis Treatment Starts Before the First Valve.Structural heart : the journal of the Heart Team · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Redo-TAVI with the SAPIEN 3 valve in degenerated calcified CoreValve/Evolut explants.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  11. Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  12. Article
  13. Impact of leaflet splitting on coronary access after redo-TAVI for degenerated supra-annular self-expanding platforms.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Gilbert H L TangDepartment of Cardiovascular Surgery, Mount Sinai Health System, New York (G.H.L.T.).ORCID 0000-0001-7219-990X
Julianne SpencerStructural Heart & Aortic, Medtronic, Mounds View, MN (J. Spencer, J.Z.S., G.S., J.J.P.).
Toby RogersSection of Interventional Cardiology, MedStar Washington Hospital Center, Washington DC (T.R.).ORCID 0000-0002-6043-3137
Kendra J GrubbDivision of Cardiothoracic Surgery (K.J.G.), Emory University, Atlanta, GA.ORCID 0000-0002-1369-5521
Patrick GleasonStructural Heart and Valve Center (K.J.G., P.G.), Emory University, Atlanta, GA.ORCID 0000-0001-5739-9030
Hemal GadaUniversity of Pittsburgh Medical Center Pinnacle Health, PA (H.G.).
Paul MahoneySentara Heart Hospital, Norfolk, VA (P.M.).
Harold L DauermanUniversity of Vermont Larner College of Medicine, Burlington (H.L.D.).
John K ForrestDivision of Cardiology, Yale School of Medicine, New Haven, CT (J.K.F.).ORCID 0000-0003-4079-3482
Michael J ReardonDepartment of Cardiovascular Surgery, Houston Methodist, TX (M.J.R.).ORCID 0000-0002-2880-6132
Philipp BlankeCenter for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada (P.B., J.A.L.).
Jonathon A LeipsicCenter for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada (P.B., J.A.L.).
Mohamed Abdel-WahabHeart Center Leipzig at University of Leipzig, Germany (M.A.-W.).ORCID 0000-0002-9596-558X
Guilherme F AttizzaniHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, OH (G.F.A.).ORCID 0000-0001-9233-1242
Rishi PuriCleveland Clinic, OH (R.P.).ORCID 0000-0001-8849-7426
Michael CaskeyAbrazo Arizona Heart Hospital, Phoenix (M.C.).
Christine J ChungDivision of Cardiology, University of Washington Medical Center, Seattle (C.J.C.).
Ying-Hwa ChenDivision of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taiwan (Y.-H.C.).ORCID 0000-0001-9321-8241
Dariusz DudekJagiellonian University Medical College, Krakow, Poland (D.D.).
Keith B AllenSt. Luke's Mid America Heart Institute, Kansas City, MO (K.B.A., A.K.C.).ORCID 0000-0001-7272-9632
Adnan K ChhatriwallaSt. Luke's Mid America Heart Institute, Kansas City, MO (K.B.A., A.K.C.).ORCID 0000-0002-5309-3058
Wah Wah HtunGundersen Health System, La Crosse, WI (W.W.H.).ORCID 0000-0002-0659-9291
Daniel J BlackmanDepartment of Cardiology, Leeds Teaching Hospitals, Leeds, United Kingdom (D.J.B.).ORCID 0000-0001-9039-6130
Giuseppe TarantiniThoracic, Vascular Sciences and Public Health, University of Padua Medical School, Italy (G.T.).ORCID 0000-0002-5055-2917
Jorge Zhingre SanchezStructural Heart & Aortic, Medtronic, Mounds View, MN (J. Spencer, J.Z.S., G.S., J.J.P.).
Greta SchwartzStructural Heart & Aortic, Medtronic, Mounds View, MN (J. Spencer, J.Z.S., G.S., J.J.P.).
Jeffrey J PopmaStructural Heart & Aortic, Medtronic, Mounds View, MN (J. Spencer, J.Z.S., G.S., J.J.P.).
Janarthanan SathananthanCenter for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada (J. Sathananthan).

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundCoronary accessibility following redo-transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients. This study aimed to predict coronary accessibility after simulated Sapien-3 balloon-expandable valve implantation within an Evolut supra-annular, self-expanding valve using pre-TAVR computed tomography (CT) imaging.

methodsA total of 219 pre-TAVR CT scans from the Evolut Low-Risk CT substudy were analyzed. Virtual Evolut and Sapien-3 valves were sized using CT-based diameters. Two initial Evolut implant depths were analyzed, 3 and 5 mm. Coronary accessibility was evaluated for 2 Sapien-3 in Evolut implant positions: Sapien-3 outflow at Evolut node 4 and Evolut node 5.

resultsWith a 3-mm initial Evolut implant depth, suitable coronary access was predicted in 84% of patients with the Sapien-3 outflow at Evolut node 4, and in 31% of cases with the Sapien-3 outflow at Evolut node 5 (

conclusionsCoronary accessibility after Sapien-3 in Evolut redo-TAVR relates to the initial Evolut implant depth, the Sapien-3 outflow position within the Evolut, and the native annular anatomy. This CT-based quantitative analysis may provide useful information to inform and refine individualized preprocedural CT planning of the initial TAVR and guide lifetime management for future coronary access after redo-TAVR. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02701283.

Indexed as

Aortic Valve StenosisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAortic ValveFeasibility StudiesHumansProsthesis DesignTomography, X-Ray ComputedTreatment Outcomeballoon-expandable valvecoronary accessimplant depthself-expanding valvetranscatheter aortic valve replacement

Identifiers

PMID37988439
PMCPMC10653288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.